173 related articles for article (PubMed ID: 34323071)
1. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
[TBL] [Abstract][Full Text] [Related]
2. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.
Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K
Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153
[TBL] [Abstract][Full Text] [Related]
4. Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
Hochscherf J; Lindenblatt D; Witulski B; Birus R; Aichele D; Marminon C; Bouaziz Z; Le Borgne M; Jose J; Niefind K
Pharmaceuticals (Basel); 2017 Dec; 10(4):. PubMed ID: 29236079
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.
Olsen BB; Rasmussen T; Niefind K; Issinger OG
Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672
[TBL] [Abstract][Full Text] [Related]
6. Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors.
Janeczko M; Masłyk M; Szyszka R; Baier A
Mol Cell Biochem; 2011 Oct; 356(1-2):121-6. PubMed ID: 21755460
[TBL] [Abstract][Full Text] [Related]
7. A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability.
Borgo C; D'Amore C; Cesaro L; Itami K; Hirota T; Salvi M; Pinna LA
Biochem Biophys Res Commun; 2020 Oct; 531(3):409-415. PubMed ID: 32800562
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.
Turowec JP; Vilk G; Gabriel M; Litchfield DW
Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180
[TBL] [Abstract][Full Text] [Related]
9. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.
Niefind K; Issinger OG
Biochim Biophys Acta; 2010 Mar; 1804(3):484-92. PubMed ID: 19796713
[TBL] [Abstract][Full Text] [Related]
10. Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias.
Klopffleisch K; Issinger OG; Niefind K
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):883-92. PubMed ID: 22868753
[TBL] [Abstract][Full Text] [Related]
11. Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2.
Baier A; Galicka A; Nazaruk J; Szyszka R
Phytochemistry; 2017 Apr; 136():39-45. PubMed ID: 28043654
[TBL] [Abstract][Full Text] [Related]
12. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
[TBL] [Abstract][Full Text] [Related]
13. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
[TBL] [Abstract][Full Text] [Related]
14. CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
Janeczko M; Orzeszko A; Kazimierczuk Z; Szyszka R; Baier A
Eur J Med Chem; 2012 Jan; 47(1):345-50. PubMed ID: 22115617
[TBL] [Abstract][Full Text] [Related]
15. A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures.
Guerra B; Bischoff N; Bdzhola VG; Yarmoluk SM; Issinger OG; Golub AG; Niefind K
ACS Chem Biol; 2015 Jul; 10(7):1654-60. PubMed ID: 25961323
[TBL] [Abstract][Full Text] [Related]
16. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
Raaf J; Klopffleisch K; Issinger OG; Niefind K
J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
[TBL] [Abstract][Full Text] [Related]
17. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
Raaf J; Brunstein E; Issinger OG; Niefind K
Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
[TBL] [Abstract][Full Text] [Related]
18. Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.
Tang S; Zhang N; Zhou Y; Cortopassi WA; Jacobson MP; Zhao LJ; Zhong RG
Mol Inform; 2019 Mar; 38(3):e1800089. PubMed ID: 30307134
[TBL] [Abstract][Full Text] [Related]
19. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
Raaf J; Issinger OG; Niefind K
J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
[TBL] [Abstract][Full Text] [Related]
20. Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library.
Mudaliar D; Mansky RH; White A; Baudhuin G; Hawkinson J; Wong H; Walters MA; Gomez-Pastor R
bioRxiv; 2024 Jan; ():. PubMed ID: 38328231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
